SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Jan-23 8:33 PM View: | Jounce Therapeutics, Inc. (JNCE) | 10-Jan-23 | Sale | 5,126 | $1.12 | $5,741.12 | (5%) 108.54K to 103.42K | |
11-Jan-23 8:33 PM View: | Jounce Therapeutics, Inc. (JNCE) | 09-Jan-23 | Sale | 4,159 | $1.10 | $4,574.90 | (4%) 112.7K to 108.54K | |
03-Feb-22 7:36 PM View: | Jounce Therapeutics, Inc. (JNCE) | 01-Feb-22 | Grant | 27,500 | -- | -- | 32% 85.2K to 112.7K | |
11-Jan-22 8:57 PM View: | Jounce Therapeutics, Inc. (JNCE) | 10-Jan-22 | Market Sale | 5,378 | $6.65 | $35,763.70 | (6%) 90.58K to 85.2K | (2%) |
11-Jan-22 8:57 PM View: | Jounce Therapeutics, Inc. (JNCE) | 07-Jan-22 | Market Sale | 3,005 | $7.30 | $21,936.50 | (3%) 93.58K to 90.58K | 7% |
31-Mar-21 8:22 PM View: | Jounce Therapeutics, Inc. (JNCE) | 31-Mar-21 | Option Exercise | 8,300 | $4.02 | $33,366.00 | 9% 93.58K to 101.89K | |
31-Mar-21 8:22 PM View: | Jounce Therapeutics, Inc. (JNCE) | 31-Mar-21 | Market Option Sale (Planned) | 8,300 | $10.09 | $83,747.00 | (8%) 101.89K to 93.58K | |
31-Mar-21 8:22 PM View: | Jounce Therapeutics, Inc. (JNCE) | 30-Mar-21 | Option Exercise | 100 | $4.02 | $402.00 | < 1% 93.58K to 93.69K | |
31-Mar-21 8:22 PM View: | Jounce Therapeutics, Inc. (JNCE) | 30-Mar-21 | Market Option Sale (Planned) | 100 | $10.00 | $1,000.00 | (< 1%) 93.69K to 93.58K | |
31-Mar-21 8:22 PM View: | Jounce Therapeutics, Inc. (JNCE) | 29-Mar-21 | Option Exercise | 5,100 | $4.02 | $20,502.00 | 5% 93.58K to 98.69K | |
31-Mar-21 8:22 PM View: | Jounce Therapeutics, Inc. (JNCE) | 29-Mar-21 | Market Option Sale (Planned) | 5,100 | $10.09 | $51,459.00 | (5%) 98.69K to 93.58K | |
03-Feb-21 5:50 PM View: | Jounce Therapeutics, Inc. (JNCE) | 01-Feb-21 | Grant | 22,250 | -- | -- | 31% 71.33K to 93.58K | |
22-Jan-21 6:40 PM View: | Jounce Therapeutics, Inc. (JNCE) | 20-Jan-21 | Option Exercise | 6,500 | $4.02 | $26,130.00 | 9% 71.33K to 77.83K | |
22-Jan-21 6:40 PM View: | Jounce Therapeutics, Inc. (JNCE) | 20-Jan-21 | Market Option Sale (Planned) | 6,500 | $12.01 | $78,065.00 | (8%) 77.83K to 71.33K | |
11-Jan-21 6:21 AM View: | Jounce Therapeutics, Inc. (JNCE) | 08-Jan-21 | Market Sale | 2,846 | $7.00 | $19,922.00 | (4%) 74.18K to 71.33K | (4%) |
11-Jan-21 6:21 AM View: | Jounce Therapeutics, Inc. (JNCE) | 07-Jan-21 | Market Sale | 2,452 | $6.76 | $16,575.50 | (3%) 76.63K to 74.18K | (8%) |
18-Aug-20 8:30 PM View: | Jounce Therapeutics, Inc. (JNCE) | 17-Aug-20 | Market Sale | 454 | $4.86 | $2,206.44 | (< 1%) 77.83K to 77.38K | (33%) |
18-Aug-20 8:30 PM View: | Jounce Therapeutics, Inc. (JNCE) | 14-Aug-20 | Market Sale | 1,728 | $4.67 | $8,070.00 | (2%) 78.36K to 76.63K | (39%) |
04-Feb-20 9:02 PM View: | Jounce Therapeutics, Inc. (JNCE) | 03-Feb-20 | Grant | 22,250 | -- | -- | 39% 56.56K to 78.81K | |
10-Jan-20 8:54 AM View: | Jounce Therapeutics, Inc. (JNCE) | 07-Jan-20 | Market Sale | 2,624 | $7.78 | $20,414.70 | (4%) 59.19K to 56.56K | 17% |
16-Aug-19 8:59 PM View: | Jounce Therapeutics, Inc. (JNCE) | 16-Aug-19 | Market Sale | 1,018 | $3.92 | $3,990.56 | (2%) 60.21K to 59.19K | (65%) |
16-Aug-19 8:59 PM View: | Jounce Therapeutics, Inc. (JNCE) | 15-Aug-19 | Market Sale | 648 | $4.00 | $2,592.00 | (1%) 60.85K to 60.21K | (62%) |
16-Aug-19 8:59 PM View: | Jounce Therapeutics, Inc. (JNCE) | 14-Aug-19 | Market Sale | 670 | $4.10 | $2,747.00 | (1%) 61.52K to 60.85K | (58%) |
05-Feb-19 6:04 PM View: | Jounce Therapeutics, Inc. (JNCE) | 01-Feb-19 | Grant | 22,250 | -- | -- | 57% 39.27K to 61.52K | |
15-Aug-18 5:28 PM View: | Jounce Therapeutics, Inc. (JNCE) | 13-Aug-18 | Grant | 14,400 | -- | -- | 58% 24.88K to 39.27K | |
12-Jun-18 6:01 PM View: | Jounce Therapeutics, Inc. (JNCE) | 08-Jun-18 | Option Exercise | 24,875 | $4.02 | $99,997.50 | 100% 0 to 24.88K | |
12-Mar-18 7:07 PM View: | Jounce Therapeutics, Inc. (JNCE) | 08-Mar-18 | Option Exercise | 4,545 | $4.02 | $18,270.90 | 100% 0 to 4.54K | |
12-Mar-18 7:07 PM View: | Jounce Therapeutics, Inc. (JNCE) | 08-Mar-18 | Market Option Sale (Planned) | 4,545 | $25.06 | $113,898.00 | (100%) 4.54K to 0 | 74% |
07-Mar-18 7:00 PM View: | Jounce Therapeutics, Inc. (JNCE) | 05-Mar-18 | Option Exercise | 4,545 | $4.02 | $18,270.90 | 100% 0 to 4.54K | |
07-Mar-18 7:00 PM View: | Jounce Therapeutics, Inc. (JNCE) | 05-Mar-18 | Market Option Sale (Planned) | 4,545 | $21.50 | $97,724.20 | (100%) 4.54K to 0 | 70% |